Adamis Pharma Price Prediction
| ADMPDelisted Stock | USD 1.74 0.24 12.12% |
Oversold Vs Overbought
42
Oversold | Overbought |
Using Adamis Pharma hype-based prediction, you can estimate the value of Adamis Pharma from the perspective of Adamis Pharma response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Adamis Pharma to buy its stock at a price that has no basis in reality. In that case, they are not buying Adamis because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Adamis Pharma after-hype prediction price | USD 1.74 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as delisted stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Adamis |
Adamis Pharma After-Hype Price Prediction Density Analysis
As far as predicting the price of Adamis Pharma at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Adamis Pharma or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Adamis Pharma, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Adamis Pharma Estimiated After-Hype Price Volatility
In the context of predicting Adamis Pharma's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Adamis Pharma's historical news coverage. Adamis Pharma's after-hype downside and upside margins for the prediction period are 1.74 and 1.74, respectively. We have considered Adamis Pharma's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Adamis Pharma is very steady at this time. Analysis and calculation of next after-hype price of Adamis Pharma is based on 3 months time horizon.
Adamis Pharma Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Adamis Pharma is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Adamis Pharma backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Delisted Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Adamis Pharma, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.00 | 0.00 | 0.00 | 0.00 | 4 Events / Month | 7 Events / Month | In about 4 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
1.74 | 1.74 | 0.00 |
|
Adamis Pharma Hype Timeline
Adamis Pharma is presently traded for 1.74. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Adamis is expected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is expected to be very small, whereas the daily expected return is presently at 0.0%. %. The volatility of related hype on Adamis Pharma is about 0.0%, with the expected price after the next announcement by competition of 1.74. About 17.0% of the company shares are held by institutions such as insurance companies. The company recorded a loss per share of 10.14. Adamis Pharma had not issued any dividends in recent years. The entity had 1:70 split on the 22nd of May 2023. Given the investment horizon of 90 days the next expected press release will be in about 4 days. Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.Adamis Pharma Related Hype Analysis
Having access to credible news sources related to Adamis Pharma's direct competition is more important than ever and may enhance your ability to predict Adamis Pharma's future price movements. Getting to know how Adamis Pharma's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Adamis Pharma may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| MNK | Mallinckrodt Plc | (0.04) | 2 per month | 13.99 | 0.03 | 12.50 | (30.95) | 504.19 | |
| LFCR | Lifecore Biomedical | 0.47 | 10 per month | 6.50 | 0.07 | 9.76 | (6.68) | 30.90 | |
| LSDI | Lucy Scientific Discovery | (0.18) | 1 per month | 27.98 | 0.21 | 550.00 | (81.82) | 3,998 | |
| ALIM | Alimera Sciences | 0.01 | 7 per month | 0.37 | 0.12 | 3.28 | (0.72) | 82.36 | |
| SHPH | Shuttle Pharmaceuticals | 0.07 | 4 per month | 0.00 | (0.14) | 10.08 | (13.02) | 50.96 | |
| ORGO | Organogenesis Holdings | 0.07 | 8 per month | 3.22 | 0.11 | 7.55 | (5.54) | 37.89 | |
| CTLT | Catalent | 0.35 | 9 per month | 0.35 | (0.13) | 1.12 | (0.65) | 3.36 | |
| TLRY | Tilray Inc | (0.04) | 11 per month | 0.00 | (0.19) | 4.94 | (4.55) | 21.22 | |
| AQST | Aquestive Therapeutics | (0.24) | 7 per month | 3.86 | 0.01 | 6.51 | (7.14) | 20.28 | |
| EVOK | Evoke Pharma | (0.22) | 7 per month | 4.59 | 0 | 6.20 | (7.18) | 48.38 | |
| GHSI | Guardion Health Sciences | 0.00 | 0 per month | 8.11 | 0.05 | 18.66 | (7.94) | 101.05 | |
| ACRX | AcelRx Pharmaceuticals | 0.02 | 1 per month | 4.26 | 0.07 | 13.85 | (8.26) | 29.52 |
Adamis Pharma Additional Predictive Modules
Most predictive techniques to examine Adamis price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Adamis using various technical indicators. When you analyze Adamis charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Adamis Pharma Predictive Indicators
The successful prediction of Adamis Pharma stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Adamis Pharma, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Adamis Pharma based on analysis of Adamis Pharma hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Adamis Pharma's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Adamis Pharma's related companies.
Story Coverage note for Adamis Pharma
The number of cover stories for Adamis Pharma depends on current market conditions and Adamis Pharma's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Adamis Pharma is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Adamis Pharma's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Adamis Pharma Short Properties
Adamis Pharma's future price predictability will typically decrease when Adamis Pharma's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Adamis Pharma often depends not only on the future outlook of the potential Adamis Pharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Adamis Pharma's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 149.9 M | |
| Cash And Short Term Investments | 1.1 M |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Other Consideration for investing in Adamis Stock
If you are still planning to invest in Adamis Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Adamis Pharma's history and understand the potential risks before investing.
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |